Sloan Sheldon insider trades
Sloan Sheldon has filed 7 Form 4s with the SEC that we hold, all for Spyre Therapeutics, Inc. (SYRE), as Chief Medical Officer. Across all of them we count 0 purchases worth $0 and 11 sales worth $7.4M reported on Form 4. In the last 12 months: 0 purchases ($0) and 11 sales ($7.4M). The largest single trade was a sale of 21,306 shares of Spyre Therapeutics, Inc. worth $1.5M, dated 2026-05-01. The first filing on our record is dated 2024-10-01 and the latest 2026-07-02.
Spyre Therapeutics, Inc. (SYRE)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2026-04-01 | S, sale reported on Form 4 | 7,958 | $397.9K | 2026-04-03 |
| 2026-05-01 | S, sale reported on Form 4 | 5,059 | $377.4K | 2026-05-01 |
| 2026-05-01 | S, sale reported on Form 4 | 10,358 | $763.8K | 2026-05-01 |
| 2026-05-01 | S, sale reported on Form 4 | 12,777 | $932.0K | 2026-05-01 |
| 2026-05-01 | S, sale reported on Form 4 | 8,777 | $628.1K | 2026-05-01 |
| 2026-05-01 | S, sale reported on Form 4 | 19,656 | $1.4M | 2026-05-01 |
| 2026-05-01 | S, sale reported on Form 4 | 400 | $30.1K | 2026-05-01 |
| 2026-05-01 | S, sale reported on Form 4 | 21,306 | $1.5M | 2026-05-01 |
| 2026-06-03 | S, sale reported on Form 4 | 8,333 | $625.0K | 2026-06-03 |
| 2026-07-01 | S, sale reported on Form 4 | 6,500 | $568.9K | 2026-07-02 |
| 2026-07-01 | S, sale reported on Form 4 | 1,834 | $162.0K | 2026-07-02 |
Counted from the Form 4 filings this reporting owner (SEC CIK 2038798) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms